BioMarin has plenty of experience launching rare disease drugs, but the company’s newest rollout will feature some notable differences from its prior marketing efforts. All …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
